PCV66 MODELED ACHIEVEMENT OF OPTIMAL LIPID VALUES AND ASSOCIATED CARDIOVASCULAR EVENT RATES WITH EXTENDED-RELEASE NIACIN/SIMVASTATIN, EZETIMIBE/SIMVASTATIN, AND INDIVIDUAL AGENTS IN A MANAGED CARE POPULATION
Abstract
Authors
SL Charland R Quimbo MJ Cziraky RA Weathermon EJ Stanek